VIEWS: 34 PAGES: 2 CATEGORY: Business & Economics POSTED ON: 6/26/2010
Critics of the industry believe that the relationships with healthcare professionals (HCP) taint their objectivity and result in overuse of branded drugs. Some also believe that online postings of company payments to healthcare professionals will lead many to reconsider their relationships with the industry. Several more companies are expected to post similar information in early 2010. It is too early to tell how these online disclosure initiatives will affect the industry and its relationships with HCPs or whether the result will be an improvement in the public's trust in the industry.
VIEWPOINT HCP disclosure: A false sense of transparency? the media were quick to run industry cannot stand alone in this data. When that happens, the Sheryl Williams their own searches and “out” the educating the public about the media and public will be able to Vice president, named physicians even further scope of the relationship and how compare and contrast the data corporate & public by running their names and the it benefits their care. the silence from each company and track affairs, Cephalon amount of their remuneration of our partners only strengthens an hCP across companies. for the local community to see. our critic’s position. it is too early to tell how these What was clear from the cov- there is no doubt that these online disclosure initiatives will erage and the response is that postings will continue to generate affect the industry and its rela- CritiCs of the industry the media and the public are believe that our relationships confused about what the data with healthcare professionals means. After all, how transparent How transparent is information when taint their objectivity and result is information when the people the people reading it have no base in overuse of branded drugs. reading it have no knowledge some also believe that online base from which to understand from which to understand the info? postings of company payments the information? if the pub- to healthcare professionals will lic doesn’t understand how interest until such time that all tionships with hCPs or whether lead many to reconsider their medicines are developed and companies have posted similar the result will be an improvement relationships with the industry. approved or who is really deter- information and there is consis- in the public’s trust in the indus- eli Lilly and Merck are the first mining whether they receive a tency in the information posted. try. What is clear is that we must companies to post their financial treatment, how can they begin to several more companies are help our companies develop the relationships on their company understand their hCP’s relation- expected to post similar infor- context for understanding this websites. Although the content ship with the industry? mation in early 2010. in addition, information and work closer with of those postings differed, the the industry’s relationship pending healthcare reform now both our healthcare professional reactions to these postings were with hCPs is a partnership and incorporates the Physicians Pay- and patient partners to drive a similar and will allow companies it is time for all of the partners ments sunshine Act, which may better understanding of the value that follow to better prepare. to stand up and be counted. the create one national standard for of these relationships. Building effective partnerships that deliver results target audience
Pages to are hidden for
"HCP disclosure: A false sense of transparency?"Please download to view full document